English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Bioreactor options for continuous cell culture-derived viral vaccine production: less defective interfering particles through process intensification

Genzel, Y., Tapia, F., Vazquez-Ramirez, D., Jordan, I., Bürgin, T., Gangemi, D. J., et al. (2016). Bioreactor options for continuous cell culture-derived viral vaccine production: less defective interfering particles through process intensification. Talk presented at BioTech 2016: Biopharmaceutical Manufacturing and Single-Use Technologies. Waedenswil, Switzerland. 2016-09-05 - 2016-09-06.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Genzel, Yvonne1, Author           
Tapia, Felipe1, 2, Author           
Vazquez-Ramirez, Daniel1, Author           
Jordan, Ingo3, Author
Bürgin, Tim4, Author
Gangemi, David J.5, Author
Reichl, Udo1, 6, Author           
Affiliations:
1Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140              
2International Max Planck Research School (IMPRS), Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738143              
3ProBioGen AG, Berlin, Germany, ou_persistent22              
4Adolf Kühner AG, Switzerland, ou_persistent22              
5Viracell Advanced Products LLC, USA, ou_persistent22              
6Otto-von-Guericke-Universität Magdeburg, External Organizations, ou_1738156              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2016
 Publication Status: Not specified
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: -
 Degree: -

Event

show
hide
Title: BioTech 2016: Biopharmaceutical Manufacturing and Single-Use Technologies
Place of Event: Waedenswil, Switzerland
Start-/End Date: 2016-09-05 - 2016-09-06
Invited: Yes

Legal Case

show

Project information

show

Source

show